feed,title,long_url,short_url
ðŸ’°Barrons,FDA's Surprise Rejection of No-Shot Alternative to EpiPen Halves Shares of ARS Pharma,https://barrons.com/articles/fda-rejects-nasal-ars-pharma-stock-epipen-b003ae71?mod=RTA,https://da.gd/kLB71
